Formula Systems (1985) Ltd: Form 20-F for the period ended Dec 31, 2014
Filed with the SEC on Apr 30, 2015 and accepted by EDGAR at Apr 30, 2015, 17:12 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2014-01-01 to 2014-12-31 | $636.4m | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months2014-01-01 to 2014-12-31 | $530.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2014-01-01 to 2014-12-31 | $106.3m | us-gaap:GrossProfit |
| Research and development | 12 months2014-01-01 to 2014-12-31 | $787.0k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2014-01-01 to 2014-12-31 | $70.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2014-01-01 to 2014-12-31 | $35.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2014-01-01 to 2014-12-31 | $4.9m | us-gaap:InterestExpense |
| Income tax | 12 months2014-01-01 to 2014-12-31 | $10.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2014-01-01 to 2014-12-31 | $80.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2014-01-01 to 2014-12-31 | $5.59 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2014-01-01 to 2014-12-31 | $5.80 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2014-01-01 to 2014-12-31 | 14,408,115 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2014-01-01 to 2014-12-31 | $16.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2014-01-01 to 2014-12-31 | $4.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2014-12-31 | $107.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-12-31 | $360.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-12-31 | $1.12bn | us-gaap:Assets |
| Current liabilities | At period end2014-12-31 | $225.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-12-31 | $115.7m | us-gaap:Liabilities |
| Shareholders' equity | At period end2014-12-31 | $388.7m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2014-12-31 | 14,719,782 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001144204-15-026652. Last ingested by Listed: Oct 24, 2026, 15:04 ET. Listed shows no prices and gives no investment advice.